Ajax-Loading

Roche Holding AG - Research and Development

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "Research-and-Development" stands at 10.11 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -23.42 percent compared to the value the year prior.
The 1 year change in percent is -23.42.
The 3 year change in percent is -25.89.
The 5 year change in percent is -32.79.
The 10 year change in percent is -31.65.

The Serie's long term average value is 15.04 Billion Swiss Francs. It's latest available value, on 06/30/2025, is 32.76 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 06/30/2025, is -53.83%.

Research and Development for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Research and Development905,699,262,464.00
LogoJohnson & Johnson - Research and Development486,508,953,600.00
LogoAbbVie Inc - Research and Development399,570,305,024.00
LogoAstraZeneca PLC - Research and Development280,205,508,085.11
LogoNovartis AG - Research and Development255,096,620,580.91